Dilnawaz F, Jena S, Nayak S
Naunyn Schmiedebergs Arch Pharmacol. 2025; .
PMID: 39777536
DOI: 10.1007/s00210-024-03751-y.
Wu S, Peng J, Lee S, Niu X, Jiang Y, Lin S
Eco Environ Health. 2024; 3(4):494-504.
PMID: 39605967
PMC: 11599990.
DOI: 10.1016/j.eehl.2024.06.001.
Sousa Ribeiro I, da Silva R, Domingues R, Leme A, Cardoso M
Beilstein J Nanotechnol. 2024; 15:1238-1252.
PMID: 39403117
PMC: 11472657.
DOI: 10.3762/bjnano.15.100.
Xu B, Li S, Shi R, Liu H
Signal Transduct Target Ther. 2023; 8(1):435.
PMID: 37996406
PMC: 10667354.
DOI: 10.1038/s41392-023-01654-7.
Li B, Liao Y, Su X, Chen S, Wang X, Shen B
J Nanobiotechnology. 2023; 21(1):325.
PMID: 37684605
PMC: 10485977.
DOI: 10.1186/s12951-023-02093-w.
A systemic review on development of mesoporous nanoparticles as a vehicle for transdermal drug delivery.
Kolimi P, Narala S, Youssef A, Nyavanandi D, Dudhipala N
Nanotheranostics. 2023; 7(1):70-89.
PMID: 36593800
PMC: 9760363.
DOI: 10.7150/ntno.77395.
Nanoparticle-based drug delivery systems for cancer therapy.
Dang Y, Guan J
Smart Mater Med. 2021; 1:10-19.
PMID: 34553138
PMC: 8455119.
DOI: 10.1016/j.smaim.2020.04.001.
A Critical Review of the Use of Surfactant-Coated Nanoparticles in Nanomedicine and Food Nanotechnology.
Miyazawa T, Itaya M, Burdeos G, Nakagawa K, Miyazawa T
Int J Nanomedicine. 2021; 16:3937-3999.
PMID: 34140768
PMC: 8203100.
DOI: 10.2147/IJN.S298606.
Delivery of Natural Agents by Means of Mesoporous Silica Nanospheres as a Promising Anticancer Strategy.
AbouAitah K, Lojkowski W
Pharmaceutics. 2021; 13(2).
PMID: 33499150
PMC: 7912645.
DOI: 10.3390/pharmaceutics13020143.
Nearly free surface silanols are the critical molecular moieties that initiate the toxicity of silica particles.
Pavan C, Santalucia R, Leinardi R, Fabbiani M, Yakoub Y, Uwambayinema F
Proc Natl Acad Sci U S A. 2020; 117(45):27836-27846.
PMID: 33097669
PMC: 7668052.
DOI: 10.1073/pnas.2008006117.
Highlights in Mesoporous Silica Nanoparticles as a Multifunctional Controlled Drug Delivery Nanoplatform for Infectious Diseases Treatment.
Carvalho G, Sabio R, Ribeiro T, Monteiro A, Pereira D, Lima Ribeiro S
Pharm Res. 2020; 37(10):191.
PMID: 32895867
PMC: 7476752.
DOI: 10.1007/s11095-020-02917-6.
Enhancing the Cellular Uptake and Antibacterial Activity of Rifampicin through Encapsulation in Mesoporous Silica Nanoparticles.
Joyce P, Ulmefors H, Maghrebi S, Subramaniam S, Wignall A, Joemetsa S
Nanomaterials (Basel). 2020; 10(4).
PMID: 32344619
PMC: 7221943.
DOI: 10.3390/nano10040815.
Safer-by-design flame-sprayed silicon dioxide nanoparticles: the role of silanol content on ROS generation, surface activity and cytotoxicity.
Rubio L, Pyrgiotakis G, Beltran-Huarac J, Zhang Y, Gaurav J, Deloid G
Part Fibre Toxicol. 2019; 16(1):40.
PMID: 31665028
PMC: 6819463.
DOI: 10.1186/s12989-019-0325-1.
Redox/pH dual stimuli-responsive ZnO QDs-gated mesoporous silica nanoparticles as carriers in cancer therapy.
Wang W, Wang Y, Wang Y, Gong H, Zhu H, Liu M
IET Nanobiotechnol. 2019; 13(6):640-649.
PMID: 31432799
PMC: 8676284.
DOI: 10.1049/iet-nbt.2019.0031.
Immunity to the Dual Threat of Silica Exposure and .
Konecny P, Ehrlich R, Gulumian M, Jacobs M
Front Immunol. 2019; 9:3069.
PMID: 30687311
PMC: 6334662.
DOI: 10.3389/fimmu.2018.03069.
Mesoporous Silica Nanoparticles: A Comprehensive Review on Synthesis and Recent Advances.
Narayan R, Nayak U, Raichur A, Garg S
Pharmaceutics. 2018; 10(3).
PMID: 30082647
PMC: 6160987.
DOI: 10.3390/pharmaceutics10030118.
Facile synthesis by a covalent binding reaction for pH-responsive drug release of carboxylated chitosan coated hollow mesoporous silica nanoparticles.
Liu Q, Wang J, Yang L, Xia X, Wang M, Chen S
IET Nanobiotechnol. 2018; 12(4):446-452.
PMID: 29768228
PMC: 8676675.
DOI: 10.1049/iet-nbt.2017.0100.
Structure Activity Relationships of Engineered Nanomaterials in inducing NLRP3 Inflammasome Activation and Chronic Lung Fibrosis.
Wang X, Sun B, Liu S, Xia T
NanoImpact. 2017; 6:99-108.
PMID: 28480337
PMC: 5415341.
DOI: 10.1016/j.impact.2016.08.002.
Differential Protein Adsorption and Cellular Uptake of Silica Nanoparticles Based on Size and Porosity.
Saikia J, Yazdimamaghani M, Moghaddam S, Ghandehari H
ACS Appl Mater Interfaces. 2016; 8(50):34820-34832.
PMID: 27998138
PMC: 5538804.
DOI: 10.1021/acsami.6b09950.
Repetitive Dosing of Fumed Silica Leads to Profibrogenic Effects through Unique Structure-Activity Relationships and Biopersistence in the Lung.
Sun B, Wang X, Liao Y, Ji Z, Chang C, Pokhrel S
ACS Nano. 2016; 10(8):8054-66.
PMID: 27483033
PMC: 5214959.
DOI: 10.1021/acsnano.6b04143.
